- Record: found
- Abstract: not found
- Article: not found
Myelodysplastic syndromes: 2018 update on diagnosis, risk-stratification and management
December 07 2017
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The myelodysplastic syndromes (MDS) are a very heterogeneous group of myeloid disorders
characterized by peripheral blood cytopenias and increased risk of transformation
to acute myelogenous leukemia (AML). MDS occurs more frequently in older males and
in individuals with prior exposure to cytotoxic therapy.